Market Cap 13,000.00
Revenue (ttm) 0.00
Net Income (ttm) -4.72M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 100
Avg Vol 28,512
Day's Range N/A - N/A
Shares Out 44.60M
Stochastic %K 3%
Beta 3.32
Analysts Strong Buy
Price Target N/A

Company Profile

NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.

Industry: Biotechnology
Sector: Healthcare
Phone: 213 642 9268
Address:
8584, Washington Street, Suite 127, Chagrin Falls, United States
Rick_Tarr
Rick_Tarr Jan. 30 at 6:22 PM
$XSNX Anyone know why this can't be bought rn ??
0 · Reply
Leilanic
Leilanic May. 16 at 2:29 PM
$XSNX woot woot. Let's see this gooooo!
0 · Reply
DekmarTrades
DekmarTrades May. 3 at 12:40 PM
Top Gainers from News and Filings this Morning: $XSNX $APSI $VAXX $WOW $WLDN
0 · Reply
SeanCharlesM
SeanCharlesM Apr. 30 at 1:54 PM
$XSNX watching
0 · Reply
Leilanic
Leilanic Apr. 30 at 1:35 PM
$XSNX signed a deal with the Cedars... Worth a look imo
0 · Reply
DonCorleone77
DonCorleone77 Mar. 1 at 2:18 PM
$XSNX NovAccess Global says financing transaction with Sumner remains pending NovAccess Global provided an update on business developments, financing and the 2024 annual meeting. The previously disclosed $10.7 million financing transaction with Sumner Global LLC remains pending, as Sumner Global has not yet obtained the funding necessary to close the transaction. To provide interim working capital, the Company's primary creditor AJB Capital Investments, LLC and another funding source have entered into separate borrowing arrangements with NovAccess Global. NovAccess Global filed its fiscal 2023 annual report on Form 10-K with the SEC on February 15, 2024 and its financial results for the first quarter of fiscal 2024 on Form 10-Q on February 27, 2024. The Company is hosting a Virtual Annual Meeting of Shareholder on Wednesday, May 6th, 2024 at 12:00 p.m. Eastern Time. Shareholders of record as of April 1st, 2024 will be able to vote and ask questions online during the meeting....
0 · Reply
Whatistruth
Whatistruth Jan. 23 at 8:21 PM
$XSNX wish I’d read and understood those filings better. Can’t afford to, file audit, can’t afford to pay back loans, can’t guarantee the .11 per share stock sale…run!
0 · Reply
Latest News on XSNX
No data available.
Rick_Tarr
Rick_Tarr Jan. 30 at 6:22 PM
$XSNX Anyone know why this can't be bought rn ??
0 · Reply
Leilanic
Leilanic May. 16 at 2:29 PM
$XSNX woot woot. Let's see this gooooo!
0 · Reply
DekmarTrades
DekmarTrades May. 3 at 12:40 PM
Top Gainers from News and Filings this Morning: $XSNX $APSI $VAXX $WOW $WLDN
0 · Reply
SeanCharlesM
SeanCharlesM Apr. 30 at 1:54 PM
$XSNX watching
0 · Reply
Leilanic
Leilanic Apr. 30 at 1:35 PM
$XSNX signed a deal with the Cedars... Worth a look imo
0 · Reply
DonCorleone77
DonCorleone77 Mar. 1 at 2:18 PM
$XSNX NovAccess Global says financing transaction with Sumner remains pending NovAccess Global provided an update on business developments, financing and the 2024 annual meeting. The previously disclosed $10.7 million financing transaction with Sumner Global LLC remains pending, as Sumner Global has not yet obtained the funding necessary to close the transaction. To provide interim working capital, the Company's primary creditor AJB Capital Investments, LLC and another funding source have entered into separate borrowing arrangements with NovAccess Global. NovAccess Global filed its fiscal 2023 annual report on Form 10-K with the SEC on February 15, 2024 and its financial results for the first quarter of fiscal 2024 on Form 10-Q on February 27, 2024. The Company is hosting a Virtual Annual Meeting of Shareholder on Wednesday, May 6th, 2024 at 12:00 p.m. Eastern Time. Shareholders of record as of April 1st, 2024 will be able to vote and ask questions online during the meeting....
0 · Reply
Whatistruth
Whatistruth Jan. 23 at 8:21 PM
$XSNX wish I’d read and understood those filings better. Can’t afford to, file audit, can’t afford to pay back loans, can’t guarantee the .11 per share stock sale…run!
0 · Reply